|
Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
|
08 September 2013 |
|
Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases
|
08 September 2013 |
|
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study
|
08 September 2013 |
|
The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation
|
06 September 2013 |
|
Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product
|
06 September 2013 |
|
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analog
|
06 September 2013 |
|
Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes
|
05 September 2013 |
|
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study
|
05 September 2013 |
|
Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation
|
05 September 2013 |
|
Effects of vitamin D on the growth of normal and malignant B-cell progenitors
|
04 September 2013 |